Expertise in
7
conditions

Side J. Liu

Guangdong Provincial Key Laboratory Of Gastroenterology, 
Guangzhou, CN 
Expertise in
7
conditions
Guangdong Provincial Key Laboratory Of Gastroenterology, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Side Liu practices in Guangzhou, China. Liu is highly rated in 7 conditions, according to our data. Their top areas of expertise are Colorectal Cancer, Stomach Cancer, Peptic Ulcer, Endoscopy, and Colonoscopy.

Their clinical research consists of co-authoring 226 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Guangdong Provincial Key Laboratory Of Gastroenterology, Guangzhou, China
Other Locations
Zhuhai, China
Hefei, 230000, China
Shenzhen, 518172, China
Nanjing, 210008, China
P.R. China 515041, Shantou, 515041, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy, Safety and Tolerability of Pradigastat in Patients With Functional Constipation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy, Safety and Tolerability of Pradigastat in Patients With Functional Constipation
Enrollment Status: Completed
Publish Date: August 24, 2022
Intervention Type: Drug
Study Drug: Pradigastat
Study Phase: Phase 2
View 1 Less Clinical Trial

224 Total Publications

Publisher Correction: RCN3 functions as a tumor promoter in colorectal cancer by modulating the GRP78-PI3K-AKT signaling pathway.
Publisher Correction: RCN3 functions as a tumor promoter in colorectal cancer by modulating the GRP78-PI3K-AKT signaling pathway.
Journal: Oncogene
Published: October 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile